Skeletal muscle mass can increase during hypertrophy or decline dramatically in response to normal or pathological signals that trigger atrophy. Many reports have documented that the number of nuclei within these cells is also plastic. It has been proposed that a yet-to-be-defined regulatory mechanism functions to maintain a relatively stable relationship between the cytoplasmic volume and nuclear number within the cell, a phenomenon known as the "myonuclear domain" hypothesis. While it is accepted that hypertrophy is typically associated with the addition of new nuclei to the muscle fiber from stem cells such as satellite cells, the loss of myonuclei during atrophy has been controversial. The intersegmental muscles from the tobacco hawkmoth Manduca sexta are composed of giant syncytial cells that undergo sequential developmental programs of atrophy and programmed cell death at the end of metamorphosis. Since the intersegmental muscles lack satellite cells or regenerative capacity, the tissue is not "contaminated" by these nonmuscle nuclei. Consequently, we monitored muscle mass, cross-sectional area, nuclear number, and cellular DNA content during atrophy and the early phases of cell death. Despite a ϳ75-80% decline in muscle mass and cross-sectional area during the period under investigation, there were no reductions in nuclear number or DNA content, and the myonuclear domain was reduced by ϳ85%. These data suggest that the myonuclear domain is not an intrinsic property of skeletal muscle and that nuclei persist through atrophy and programmed cell death.
SKELETAL MUSCLE is the largest tissue by mass within the vertebrate body and serves as the organism's primary reservoir of amino acids. Resistance exercise and/or use of anabolic steroids leads to enhanced muscle growth (hypertrophy) and concomitant increases in mass, fiber cross-sectional area, and strength, while starvation, cachexia, or inactivity trigger muscle atrophy and a decline in these same parameters (reviewed in Ref. 62) .
It has long been held that the number of nuclei within a muscle is also plastic, increasing during both early development and hypertrophy to meet the enhanced protein synthetic demands of the larger cell (18, 46, 61) , while decreasing during atrophy to remove surplus nuclei (81) . As a result, it has been proposed that the cytoplasmic volume supported by a single nucleus remains relatively constant in muscle (1, 32, 72) . First presented by Strassburger in 1893 (77) as "Wirkungssphäre," or "sphere of influence," as a general property of cells, this relationship is more typically referred to as the "myonuclear domain" in the field of muscle biology (reviewed in Refs. 57, 80, and 83) .
There has been general agreement that new nuclei are added to the muscle fiber during maturation and that hypertrophy occurs predominantly via the incorporation of lineage-restricted muscle stem cells known as satellite cells (10) . Satellite cells reside outside the muscle fiber between the sarcolemma and the basement membrane (38, 44) and can be induced to proliferate in response to a number of stimuli, including focal damage resulting from strenuous work (reviewed in Refs. 21 and 86) . Once activated, these cells pursue one of three potential fates: some cells fuse with the muscle fiber to contribute new nuclei; some exit the cell cycle, arrest, and replenish the satellite cell pool; and the remaining cells initiate apoptosis and die (64) . This process ensures maintenance of both the muscle fiber and the satellite cell pool.
In contrast, skeletal muscle atrophy is accompanied by a dramatic increase in the number of apoptotic nuclei within the tissue (3, 4, 7, 15, 56, 74, 78) . This apoptosis can occur in a caspase-dependent (48) or -independent (1, 43) manner and results in the loss of large numbers of nuclei.
Several studies have questioned the existence of a myonuclear domain (5, 31, 34, 85, 89) . For example, in an elegant series of studies, Gundersen et al. used fluorescent dyes to independently label the nuclei and the cytoplasm of individual muscle fibers in vivo and then monitored nuclear number and position over time following various experimental manipulations (11) (12) (13) 24) . Their data support the contention that nuclei are almost never lost from atrophic muscle, thus contradicting the myonuclear domain hypothesis.
One reason for these seemingly contradictory results is that mammalian muscle is a complex tissue that contains not only multiple muscle fiber types, each of which has its own relative myonuclear density (82) , but also a variety of distinct cell types, including satellite cells, stromal cells, endothelial cells, fibroblasts, pericytes, and macrophages (79) . Consequently, it is challenging to unambiguously determine the identity of any given nucleus under investigation within the tissue. Another complication is the wide range of nonphysiological manipulations, including denervation, immobilization, sepsis, glucocorticoids, tenotomy, cancer cachexia, and weightlessness, that researchers employ to trigger atrophy (25, 27, 29, 50, 55, 58, 61, 73, 88) . These various models may not reflect the native mechanisms that are employed during normal development or aging. An additional issue is that the contralateral muscle is often used as an internal experimental control, which is problematic if there are broader systemic effects that impact all muscles, such as circulating stress hormones (9) or altered neuronal activity (33, 87) . Lastly, it can take weeks or months to achieve a significant change in muscle mass or crosssectional area in many models of atrophy in rodents (16) and humans (39) . For example, even under extreme conditions, a 20% loss of mass in human quadriceps femoris muscle requires 4 -6 wk of muscle unloading (20) . In an extreme but clinically important example, individuals with sarcopenia lose~1% of muscle mass per year, meaning that a 30% reduction in muscle mass can take several decades (53) .
An alternative approach for testing the fundamental validity of the myonuclear domain hypothesis would be to employ an animal model that is not complicated by any of these confounding issues. One candidate for such an analysis is the intersegmental muscle (ISM) from the tobacco hawkmoth Manduca sexta (26) . The ISMs are organized as sheets of individual giant muscle fibers (each syncytial cell is ϳ5 mm long and up to 1 mm in diameter) (41) (Fig. 1A ) that attach at the segmental boundaries within the abdomen. Contraction of these muscles allows the larva (caterpillar) to crawl and the developing adult moth to eclose (emerge) from the overlying pupal cuticle at the end of metamorphosis. A quantitative analysis of ISM development revealed that, beginning on day 15 of the normal 18 days of pupal-to-adult development, the ISMs initiate a program of atrophy that results in a 40% loss of muscle mass by the time of adult eclosion late on day 18 (69) . ISM atrophy occurs without overt changes in physiological properties of the muscle, such as resting potential or tetanic force per crosssectional area (67) . Late on day 18, coincident with adult eclosion, the ISMs initiate programmed cell death and disappear during the subsequent 30 h (41, 70) (Fig. 1A) . ISM death represents a fundamentally distinct developmental program rather than the continuation of the atrophy process since it is regulated by different endocrine triggers, is dependent on de novo gene expression, and results in the loss of basic physiological properties such as contractility and a resting potential (8, 66, 67) .
In contrast to mammalian muscle, ISMs do not contain capillaries, satellite cells, endothelial cells, or pericytes (8) . In addition, ISMs are not phagocytosed when they die following adult eclosion (36) , which means that macrophage-like cells do not contaminate the preparation during atrophy or death.
In the current analysis of Ͼ500 individual ISM fibers, we observed that the number of myonuclei and muscle DNA content remain unchanged during development, despite a profound loss of both muscle mass and volume. These data suggest that maintenance of the myonuclear domain is not an intrinsic property of skeletal muscle during physiological atrophy or death.
MATERIALS AND METHODS
Animals. Tobacco hawkmoths, Manduca sexta, were reared and staged as described previously (69) . Abdomens were isolated from staged animals and pinned at length under ice-cold saline (69) . One strip of the lateral ISMs was dissected free, placed on preweighed foil, and dried overnight at 60°C. The foil was reweighed, and the mass of the muscles was used to determine the somatic index: [(mg ISM dry wt ϫ 2)/g body wt] ϫ 1,000. The remaining strip of ISM was left in situ and fixed overnight at 4°C in 70% ethanol for DNA isolation (see below) or 4% paraformaldehyde in Manduca saline for histology. There were no gross changes in fiber volume with paraformaldehyde fixation (65) .
Histology. For whole-mount images, fixed ISM fibers were cleared in glycerol and the DNA was stained with 4=,6-diamidino-2-phenylindole (DAPI; Sigma). Fibers were imaged using a ϫ10 objective on a Zeiss Axioplan 2 equipped with a Zeiss Apotome to obtain confocal images. For sectioned material, ISMs were dehydrated through an ethanol series, embedded in paraffin, and cut to a thickness of 10 m, and every fifth section was mounted on a glass slide for DAPI staining. Fluorescence images were collected on a Nikon Eclipse TE-2000-S fluorescence microscope and analyzed with MetaVue software (Molecular Devices). We collected data (cross-sectional area and nuclear number) for ϳ5-10 fibers per animal for 3 independent animals per developmental stage.
The number of nuclei per millimeter of fiber (x) was found using the following calculation:
where n is the number of myonuclei per fiber cross section, L is the length of the fiber, d is the thickness of the section, and l is the mean length of a muscle nucleus (63) . The myonuclear domain (MND) was determined using the following calculation: MND ϭ CL/x, where C represents the crosssectional area of the muscle fiber (35) . DNA isolation and analysis. For analysis of genomic DNA, Ն5 animals were used for each time point, and 10 individual ISM fibers were sampled from each animal for a total of Ն50 individual fibers per developmental stage. To help ensure uniformity, all fibers were taken from the fifth abdominal segment, which corresponds to the second segment in Fig. 1A .
Individual muscle fibers were placed in microfuge tubes containing lysis buffer [10 mM Tris (pH 8.0), 100 mM NaCl, 10 mM EDTA (pH 8.0), and 0.5% SDS] plus 400 g/ml proteinase K (Invitrogen) for 2 h at 55°C with agitation. One-half volume of 6 M NaCl was added, and DNA was precipitated with isopropranol on ice, pelleted at 14,000 g for 10 min at room temperature, and then resuspended in 20 l of 10 mM Tris (pH 7.5), 1 mM EDTA (pH 7.5), and 200 g/ml RNase A (Sigma). DNA was quantified using a spectrophotometer (NanoDrop 1000, Thermo Scientific). Some DNA samples were subjected to electrophoresis in 0.8% agarose gels and stained with ethidium bromide.
Statistical analysis. Generalized estimating equation (GEE) methods were used to evaluate changes in ISM properties during development ("day 13" through "18 h post-eclosion"), thus taking into account the correlation of replicate measurements on the same animal. This approach has the advantage of yielding correct estimates of standard error and well-defined tests of statistical significance. Specifically, we fit population-averaged models in which changes over time were modeled using design variables. We further assumed normality and an exchangeable correlation structure. All analyses were performed in Stata version 14 (76) .
RESULTS

Analysis of ISM size and nuclear number during atrophy and death.
The ISMs are composed of bilateral sheets of muscle fibers that span abdominal segments 4 -8 in developing adult moths. We observed ϳ15 fibers per hemisegment, a number that did not change during pupal-to-adult development (Fig.  1A) . However, between days 15 and 18 the ISMs atrophied and became progressively thinner. After adult eclosion, a behavior generated by the ISMs, the fibers underwent programmed cell death and rapidly lost both mass and contractility. To quantify these changes, we determined ISM dry weight at each developmental stage and then normalized it to the weight of the animal. This somatic index was constant in this population of animals until day 16 and then began to decline, so that by the time of adult eclosion late on day 18, the muscles had lost ϳ38% of their mass (Fig. 1, A and B) . During this period, the ISMs remained functional and were able to generate vigorous contractions when stroked with metal forceps (data not shown). Muscle mass was lost rapidly following adult eclosion (Fig. 1,  A and B) , and by 18 h post-eclosion, muscles were no longer contractile. (We did not look at later times after adult eclosion, because the dying fibers became too fragile to isolate in an intact state, a requirement for some of the experiments described below).
To begin evaluating the number of nuclei within the ISM during development, we fixed muscles from three different stages, stained them with DAPI to label the nuclei, and then imaged them via confocal microscopy. Unlike mammalian muscles, which have a relatively modest number of nuclei arrayed along the periphery of the fibers, the ISMs have a prodigious number of nuclei throughout the muscle ( Fig. 2A) . Between day 15 and day 18, when the muscles had lost ϳ38% of their mass due to atrophy, the volume of the fiber decreased, but qualitatively the number of nuclei was not dramatically altered. During the subsequent 18 h, when the muscles were actively dying, fiber volume declined drastically, but again the nuclei persisted, albeit at a much higher density. Since the area shown is ϳ20% of the length of these fibers, it would be challenging to obtain accurate nuclear counts from wholemount preparations. Consequently, we fixed the muscles at length, embedded them in paraffin, and stained 10-m sections with DAPI at three key stages: homeostatic (day 15; Fig. 2B , Fig. 2 . Nuclear staining in ISMs during atrophy and death. A: ISMs were fixed at length in situ at 3 stages of development: homeostatic (day 15 of pupal-to-adult development, top), atrophic (day 18, middle), and dying (18 h post-eclosion, bottom), cleared, and stained with the nuclear dye DAPI. Fibers were then imaged via confocal microscopy. B: ISM fibers from approximately the same stages were embedded in paraffin, sectioned to 10 m, and stained with DAPI. Note dramatic loss of muscle protein (lightgray area) during atrophy and death. top), atrophic (pre-eclosion on day 18; Fig. 2B, middle) , and actively dying (16 h post-eclosion; Fig. 2B, bottom) . Between days 15 and 18, the cross-sectional area of the ISMs declined ϳ49%, from a mean of 59,616 m 2 to 30,278 m 2 (Fig. 3A) . By 16 h post-eclosion, the area had fallen to 12,738 m 2 , for a total decline of 79%. During this same period, the number of nuclei per cross section remained unchanged (P ϭ 0.57; Fig.  3B ). This means that there was functionally a 4.4-fold increase in the number of nuclei per square millimeter of muscle membrane from day 15 to 16 h post-eclosion. To determine the myonuclear domain, we calculated the volume of cytoplasm per nucleus (Fig. 3C) . During ISM atrophy and death, the myonuclear domain decreased from 1.88 mm 3 /nucleus on day 14 to 0.29 mm 3 /nucleus at 16 h post-eclosion, an 84% reduction.
Quantification of ISM DNA content during atrophy and death. Given the large number of nuclei within each fiber ( Fig.  2A) , it is not practical to individually count all the nuclei in whole mounts. Counting nuclei within sections can be also imprecise, since nuclei are not uniformly distributed along the entire length of muscle fibers (59) and histological manipulations can alter fiber cross-sectional area (40) . An alternative strategy is to quantify the amount of DNA in individual cells and use that as a surrogate for nuclear number. Since the ISMs have a fairly uniform size and are not attached to neighboring fibers (Figs. 1A and 2A), they can be readily isolated individually for biochemical studies. As a first test of this approach, we isolated DNA from individual muscle fibers at multiple different stages of pupal-to-adult development (day 13 to 18 h post-eclosion) and then fractionated the isolated DNA by size in agarose (Fig. 4A) . Comparable amounts of high-molecularweight DNA were present from each stage examined, without detectable contamination from ribosomal RNA or lower-molecular-weight DNA fragments that might form during apoptosis (68) . These qualitative data suggest that 1) there is no gross change in DNA content during development and 2) the samples are not contaminated by other nucleic acids that might complicate analyses.
We then isolated DNA from 420 individual fibers from animals between day 13 of development and 18 h post-eclosion and quantified it spectrophotometrically. We found ϳ2.0 g of DNA per fiber, an amount that did not change significantly (P ϭ 0.19) during atrophy or death (Fig. 4B) .
When we normalized muscle fiber DNA content to the mass of the muscles during development, we observed a ϳ1.7-fold increase in the relative DNA concentration between day 16 and 18 h post-eclosion (Fig. 4C ). In agreement with our nuclear counts (Fig. 3) , these data suggest that nuclei are not being lost during either atrophy or death.
DISCUSSION
Muscle contraction allows animals to secure food, avoid predation, and participate in mating and therefore has been presumably subjected to strong selective pressure. Since muscle strength is roughly proportional to its cross-sectional area (30), it is not surprising that muscles are the largest cells in the vertebrate body and can achieve volumes more than a million times greater than the volume of most somatic cells (14) . The production and maintenance of the contractile apparatus require prodigious protein synthetic capacity that is beyond the limit of individual nuclei (19) , so there is likely an advantage for muscles to evolve the capacity to form syncytia. Within a muscle fiber, each nucleus appears to support a finite volume of cytoplasm, a phenomenon that is referred to as the myonuclear domain (84) . Some of the most convincing data supporting this hypothesis have come from studies that localize mRNAs de- rived from individual nuclei. For example, mRNA encoding the acetylcholine receptor is produced by subsarcolemmal nuclei, and these transcripts are restricted to that region of the cell (49) . More recent studies examining myonuclei that were individually infected with influenza virus have confirmed that newly synthesized mRNAs remain predominantly in the perinuclear and subsarcolemmal region of the nucleus where they were produced (52) .
New nuclei are added to muscles as they grow during development to meet the greater synthetic demands of the enlarging cell (10) . These new nuclei are acquired from exogenous stem cells, typically satellite cells, at a rate that is roughly proportional to the growth of the fiber, which serves to maintain the myonuclear domain in these hypertrophic muscles (51) . The addition of the new nuclei parallels muscle growth (75) but is not an absolute requirement for muscle growth, since muscles can still initiate hypertrophy in mice where the satellite cell pool has been ablated genetically (47) . Under these circumstances, the myonuclear domain ratio is not maintained and functionally increases 32%, suggesting that the myonuclear domain ratio is not rigid. Indeed, there is no one generic myonuclear domain size as it can range dramatically during development. For example, a study of thoracoabdominal muscles in children showed a nearly fivefold increase in the myonuclear domain between birth and adolescence (18) . Nevertheless, it is well accepted that muscle growth and hypertrophy typically involve the addition of new nuclei.
The fate of muscle nuclei during atrophy is less clear and the subject of debate: some reports demonstrate that nuclei persist during atrophy (5, 31, 34, 89) , while others document the apparent loss of nuclei coincident with a reduction in fiber cross-sectional area (1, 3, 32, 48, 54, 56) . In most cases, the data supporting myonuclear loss have been obtained using whole muscle tissue rather than individual myofibers. Given that muscles are heterogeneous tissues with multiple distinct cell types (79) , it is often difficult to determine conclusively that a specific nucleus resides within or outside the sarcolemma and therefore, many of the nuclei that are lost may not be true myonuclei. In a series of carefully controlled studies, Gundersen et al. labeled myonuclei in single mouse muscle fibers in vivo with fluorescent dyes and then monitored their location and fate over time (11) (12) (13) 24) . They were able to document the anticipated addition of new nuclei during muscle hypertrophy (13) , but failed to observe the loss of nuclei during muscle atrophy (12, 24) . In fact, in one study where they counted ϳ200,000 myonuclei in atrophic muscles, only 4 TUNELpositive (apoptotic) nuclei were observed, a loss that represents only ϳ0.002% of the myonuclei (11) .
Virtually all the studies examining changes in myonuclear domain during atrophy have employed experimental interventions, including denervation, hindlimb suspension, spinal cord injury, spaceflight, or tenotomy (5, 12, 17, 37, 89) . These manipulations, as well as animal handling, may induce the secretion of stress hormones, which can also influence the progression of atrophy (2, 6) . Consequently, we chose to employ a model where atrophy is initiated endogenously as a normal component of development (69, 70 ). An additional benefit of this model is that the muscle subsequently undergoes programmed cell death, so it is possible to examine the fate of nuclei during both of these distinct degenerative processes (28, 41, 70) . In the current study we observed that the ISMs lost 38% of their mass (Fig. 1B) and 49% of their cross-sectional area during the period of atrophy (days 15-18 of pupal-to-adult development; Fig. 3A ) and an additional 36% of their mass (Fig. 1B) and 29% of their cross-sectional area (Fig. 3A) during the first 16 h after the initiation of programmed cell death. Thus the muscles lost 74% of their mass and 79% of their crosssectional area during this ϳ85-h window. Since fiber volume is proportional to cross-sectional area, and the muscles attach at the intersegmental boundaries which are at a fixed length, there is also presumably an ϳ80% reduction in volume (Fig. 1A) . Despite these dramatic declines, the number of nuclei did not change during these processes (Fig. 3B) . Functionally, this means that the myonuclear domain decreased 52%, from 1.9 to 0.90 m 3 /myonucleus during atrophy and then fell to 0.29 m 3 /myonucleus during the first 16 h of death. This represents an overall loss of 87%.
Because the ISMs consist of very large and discrete cells that are not appreciably "contaminated" with many other cell types, we were able to quantify the DNA content of individual fibers biochemically as a complementary method for monitoring nuclear number. In some ways this approach may represent a more accurate measure of nuclear content, since nuclei are not uniformly distributed along the length of muscle fibers (59) . Using this method, we observed that the DNA content of the muscles remained constant during both atrophy and the early stages of programmed cell death, again suggesting that nuclei were not lost. Since the muscles lose both mass and volume during these time periods, there was a functional 1.7-fold increase in the DNA content per milligram of muscle dry weight (Fig. 4C) . This increase is consistent with the 84% decrease in the myonuclear domain size calculated from anatomic studies (Fig. 3C) . Thus, with use of two independent methods, the traditional anatomic analysis of nuclear number and the biochemical approach of quantifying DNA content, our findings suggest that there is no compensatory loss of nuclei during ISM atrophy or death. These data agree well with comparable studies in mice (11) , suggesting that this is a common property of striated skeletal muscle.
The mechanism of cell death employed by the ISMs does not appear to be apoptosis. The hallmarks of apoptosis, DNA fragmentation to 180-bp ladders and deposition of electrondense chromatin along the inner aspect of the nuclear envelope as revealed by transmission electron microscopy, are not seen in the ISMs (68) (Fig. 4A) . In addition, the ISMs do not bleb during death, nor are they phagocytosed, two additional events observed in most apoptotic deaths (36, 68) .
Both caspase-dependent caspase-activated nuclease (CAD) and caspase-independent endonuclease G (EndoG)-mediated nuclear destruction have been proposed as mechanisms for the apoptotic loss of nuclei in mammalian skeletal muscles (3, 23) . Independent of the DNase involved, there is an inherent teleological problem with the apoptotic elimination of individual nuclei within a syncytial cell. Since all the nuclei reside within a common cytoplasm, it is difficult to envision a mechanism that could restrict the destruction to a discrete subset of nuclei without risking damage to adjacent nuclei. Activated caspases cleave the prodomains of inactive executioner caspases, which would, in turn, likely drive a spreading wave of active proteases that would be destructive to both cytoplasmic and nuclear structures. For example, the human syncytiotrophoblast is a syncytial tissue that surrounds the placenta and is composed of ϳ5 ϫ 10 10 nuclei (45) . When apoptosis occurs in the syncytiotrophoblast, it propagates as a wave throughout the entire structure at a rate of ϳ5 m/min until the entire tissue is involved (42) . A similar process in muscle would likely involve more than the occasional nucleus.
Not only is it unclear how nuclei might be lost from mature muscle, it is not clear that this would confer an advantage to the organism. In fact, the retention of these "surplus" nuclei during atrophy has been proposed to represent the basis for the phenomenon of "muscle memory," whereby functional recovery takes place more quickly during subsequent periods of training relative to the first bout (13, 24) . Since environmental conditions often fluctuate, and skeletal muscle frequently goes through cycles of atrophy and hypertrophy, the ability to recover quickly by utilizing preexisting nuclei may play an important role in muscle adaptation.
Insight into the regulation of nuclear number during growth and atrophy is not just of interest for understanding the basic biology of muscle, it also has potential clinical implications. Muscle weakness is a major mediator of mortality and morbidity in human disease (71) . The measures that are employed to counter the effects of atrophy will likely differ depending on the underlying mechanism(s). For example, if the atrophic muscle already has adequate synthetic capacity from its previously acquired "surplus myonuclei," then exercise and nutrition may be of more immediate benefit for recovery of muscle strength than a stem cell-based therapy designed to add new nuclei.
In summary, we did not detect the loss of myonuclei or genomic DNA during skeletal muscle atrophy. These data are consistent with several other published reports and suggest that the nuclear elimination in support of the myonuclear domain size is not a fundamental component of skeletal muscle. We have also demonstrated that the destruction and/or elimination of nuclei does not appear to occur in this model of skeletal muscle programmed cell death.
